- Kristi Powers

The Food and Drug Administration (FDA) recently approved a new drug to treat Type 1 diabetes and AdventHealth contributed to the large global screening effort that make groundbreaking studies like this possible. Now, AdventHealth is one of a handful of hospital systems approved to distribute this medication.
This breakthrough treatment, called TZIELD, is the first drug that can delay the progression of Type 1 diabetes by up to three years in adults and up to eight years in children. To determine eligibility for the treatment, a simple blood test is performed. If the blood test is positive, then an oral glucose tolerance test is administered to see if the blood glucose is increasing.

“For the first time, a disease we thought was inevitable, can now be delayed,” said Anna Casu, MD, associate investigator in Type 1 diabetes research at the AdventHealth Translational Research Institute. “Now there’s a reason for screening for Type 1 diabetes because its burden can be delayed. This innovation drives me to continue our research to uncover a cure.”
The study, leading to TZIELD approval, was conducted by the Type 1 Diabetes TrialNet Consortium, which screened roughly 200,000 participants for Type 1 diabetes. AdventHealth served as a screening site.
Over the last four years, the findings were analyzed, published in the New England Journal of Medicine and then sent to the FDA for approval.

“Diabetes is a disease that never goes away, so a delayed diagnosis with treatment like this drug can have a significant impact on quality of life for the patient and their family,” said Konda M. Reddy, MD, medical director of Pediatric Endocrinology and Diabetes at AdventHealth for Children. “This is a historic moment for the Type 1 diabetes community. It means there’s more time to live without the burden of the disease and complications.”
Type 1 diabetes is a disease that occurs when the immune system attacks and destroys the cells that make insulin. According to the Juvenile Diabetes Research Foundation, some 1.45 million Americans are living with Type 1 diabetes and 64,000 are diagnosed each year in the U.S.
Patients or referring physicians who are interested in starting the screening process, please contact Dr. Reddy’s office at Call407-896-2901.
Recent News
Dr. Jason Jennings, orthopedic surgeon with AdventHealth Medical Group Colorado Joint Replacement at Porter, was selected to present his research findings at the 3rd International Consensus Meeting on...
When it comes to back health, how you sleep matters just as much as how you move during the day. According to Dr. Sharad Rajpal, a neurosurgeon at AdventHealth Avista, your nighttime habits can either...
Personal experiences and the desire to give back inspired AdventHealth Avista ICU Manager Megan May to pursue a career in nursing. Her journey began in the very halls of Avista, where as a child she...
July marks Fibroid Awareness Month—a time to spotlight a condition that affects an estimated 26 million women across the United States.
Aimee Keller-Pickford to serve as CEO of AdventHealth Winter Garden; Sheila Rankin to lead AdventHealth Winter Park.
AdventHealth is pleased to announce the appointment of Bela Nand, MD, as the new Regional Chief Medical Officer for the Mid-America Region, effective June 29, 2025.
This national recognition honors nurses who exemplify clinical excellence, compassionate care, and a deep commitment to the healing ministry of Christ.
For Amanda Jackson, ICU Manager at AdventHealth Porter, nursing is more than a profession—it’s a calling shaped by profound personal experiences and a deep-rooted desire to care for others.
AdventHealth Manchester is proud to recognize a group of exceptional seniors from Clay County High School who have been awarded scholarships in support of their academic and professional aspirations. ...
With nearly three decades of health care experience, Biri will lead AdventHealth’s flagship facility.
From paralysis to running and wedding planning in just a few months, Gus defied the odds after being diagnosed with a rare autoimmune disorder with the help of his doctors and rehab team.
UChicago Medicine AdventHealth finance leadership resident Nikita Voroniuk was living in a rural Russian town until his life took a very unexpected turn.